Germinal and somatic trisomy 21 mosaicism: How common is it, what are the implications for individual carriers and how does it come about?

Current Genomics

Volumn 11, Issue 6, 2010, Pages 409-419

  Hultén, Maj A ^a   Jonasson, Jon ^b   Nordgren, Ann ^c   Iwarsson, Erik ^c  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Cancer; Childhood leukemia; Fetus; Germ line; Mosaicism; Trisomy 21

Indexed keywords

AGING; ALZHEIMER DISEASE; ARTICLE; CANCER RISK; CHILD; CHROMOSOME 21; DERMATOGLYPHICS; DOWN SYNDROME; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC RISK; HETEROZYGOTE; HUMAN; LEUKEMIA; MATERNAL AGE; MOSAICISM; OOCYTE; PREMATURE AGING; SEMEN ANALYSIS; SOLID TUMOR; TESTIS; TRISOMY 21;

EID: 78650018924     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920210793176056     Document Type: Article

References (143)

1. Kovaleva, N.V. Germ-line transmission of trisomy 21: Data from 80 families suggest an implication of grandmaternal age and a high frequency of female-specific trisomy rescue. Mol. Cytogenet., 2010, 3, 7.
2. Gautier, M.; Harper, P.S. Fiftieth anniversary of trisomy 21: returning to a discovery. Hum. Genet., 2009, 126, 317-324.
3. Jacobs, P.A.; Baikie, A.G.; Court Brown, W.M.; Strong, J.A. The somatic chromosomes in mongolism. Lancet, 1959, 1, 710.
4. Katznelson, M.B.; Bejerano, M.; Yakovenko, K.; Kobyliansky, E. Relationship between genetic anomalies of different levels and deviations in dermatoglyphic traits. Part 4: Dermatoglyphic peculiarities of males and females with Down syndrome. Family study. Anthropol. Anz., 1999, 57, 193-255.
5. Kücken, M. Models for fingerprint pattern formation. Forensic Sci. Int., 2007, 171, 85-96.
6. Lejeune, J.; Turpin, R.; Gautier, M. Mongolism; a chromosomal disease (trisomy). Bull. Acad. Natl. Med., 1959, 143, 256-265.
7. Mardia, K.V.; Li, Q.; Hainsworth, T.J. On the Penrose hypothesis on fingerprint patterns. IMA J. Math. Appl. Med. Biol., 1992, 9, 289-294.
8. Penrose, L.S. The distal triradius t on the hands of parents and sibs of mongol imbeciles. Ann. Hum. Genet., 1954, 19, 10-38.
9. Berkova, A.; Zemanova, Z.; Trneny, M.; Schwarz, J.; Karban, J.; Cmunt, E.; Pavlistova, L.; Brezinova, J.; Michalova, K. Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization. Neoplasma, 2009, 56, 455-458.
10. de Arruda Cardoso Smith, M.; Borsatto-Galera, B.; Feller, R.I.; Goncalves, A.; Oyama, R.S.; Segato, R.; Chen, E.; Carvalheira, G.M.; Filho, A.S.; Burbano, R.R.; Payao, S.L. Telomeres on chromosome 21 and aging in lymphocytes and gingival fibroblasts from individuals with Down syndrome. J. Oral. Sci., 2004, 46, 171-177.
11. DeUgarte, C.M.; Li, M.; Surrey, M.; Danzer, H.; Hill, D.; DeCherney, A.H. Accuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis. Fertil. Steril., 2008, 90, 1049-1054.
12. Hultén, M.A.; Dhanjal, S.; Pertl, B. Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. Reproduction, 2003, 126, 279-297.
13. Iourov, I.Y.; Soloviev, I.V.; Vorsanova, S.G.; Monakhov, V.V.; Yurov, Y.B. An approach for quantitative assessment of fluorescence in situ hybridization (FISH) signals for applied human molecular cytogenetics. J. Histochem. Cytochem., 2005, 53, 401-408.
14. Iourov, I.Y.; Vorsanova, S.G.; Yurov, Y.B. Intercellular Genomic (Chromosomal) Variations Resulting in Somatic Mosaicism: Mechanisms and Consequences. Curr. Genomics, 2006, 7, 435-446.
15. Lomax, B.L.; Kalousek, D.K.; Kuchinka, B.D.; Barrett, I.J.; Harrison, K.J.; Safavi, H. The utilization of interphase cytogenetic analysis for the detection of mosaicism. Hum. Genet., 1994, 93,243-247.
16. Modi, D.; Berde, P.; Bhartiya, D. Down syndrome: a study of chromosomal mosaicism. Reprod. Biomed. Online, 2003, 6, 499-503.
17. Shi, Q.; Adler, I.D.; Zhang, J.; Zhang, X.; Shan, X.; Martin, R. Incidence of mosaic cell lines in vivo and malsegregation of chromosome 21 in lymphocytes in vitro of trisomy 21 patients: detection by fluorescence in situ hybridization on binucleated lymphocytes. Hum. Genet., 2000, 106, 29-35.
18. Shi, Q.; Chen, J.; Adler, I.; Zhang, J.; Martin, R.; Pan, S.; Zhang, X.; Shan, X. Increased nondisjunction of chromosome 21 with age in human peripheral lymphocytes. Mutat. Res., 2000, 452, 27-36.
19. Vorsanova, S.G.; Yurov, Y.B.; Iourov, I.Y. Human interphase chromosomes: a review of available molecular cytogenetic technologies. Mol. Cytogenet., 2010, 3, 1.
20. Hook, E.B. Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. Am. J. Hum. Genet., 1977, 29, 94-97.
21. Hultén, M.A.; Gould, C.P.; Goldman, A.S.; Waters, J.J. Chromosome in situ suppression hybridisation in clinical cytogenetics. J. Med. Genet., 1991, 28, 577-582.
22. Iourov, I.Y.; Liehr, T.; Vorsanova, S.G.; Yurov, Y.B. Interphase chromosome-specific multicolor banding (ICS-MCB): a new tool for analysis of interphase chromosomes in their integrity. Biomol. Eng., 2007, 24, 415-417.
23. Iourov, I.Y.; Vorsanova, S.G.; Yurov, Y.B. Chromosomal mosaicism goes global. Mol. Cytogenet., 2008, 1, 26.
24. Hultén, M.A.; Patel, S.D.; Tankimanova, M.; Westgren, M.; Papadogiannakis, N.; Jonsson, A.M.; Iwarsson, E. On the origin of trisomy 21 Down syndrome. Mol. Cytogenet., 2008, 1, 21.
25. Hultén, M.A.; Patel, S.; Jonasson, J.; Iwarsson, E. On the origin of the maternal age effect in trisomy 21 Down syndrome: the Oocyte Mosaicism Selection model. Reproduction, 2010, 139, 1-9.
26. Cui, Y.X.; Hao, L.J.; Wang, Y.H.; Xia, X.Y.; Shi, Y.C.; Lu, H.Y.; Yao, B.; Huang, Y.F. Second pregnancy of trisomy 21 in a mother with mosaicism. Chin. Med. J. (Engl), 2007, 120, 1295-1296.
27. De Souza, E.; Halliday, J.; Chan, A.; Bower, C.; Morris, J.K. Recurrence risks for trisomies 13, 18, and 21. Am. J. Med. Genet. A, 2009, 149A, 2716-2722.
28. James, R.S.; Ellis, K.; Pettay, D.; Jacobs, P.A. Cytogenetic and molecular study of four couples with multiple trisomy 21 pregnancies. Eur. J. Hum. Genet., 1998, 6, 207-212.
29. Migliore, L.; Migheli, F.; Coppede, F. Susceptibility to aneuploidy in young mothers of Down syndrome children. Scientific World Journal, 2009, 9, 1052-1060.
30. Hultén, M.A.; Patel, S.D.; Westgren, M.; Papadogiannakis, N.; Jonsson, A.M.; Jonasson, J.; Iwarsson, E. On the paternal origin of trisomy 21 Down syndrome. Mol. Cytogenet., 2010, 3, 4.
31. Gazvani, M.R.; Wilson, E.D.; Richmond, D.H.; Howard, P.J.; Kingsland, C.R.; Lewis-Jones, D.I. Role of mitotic control in spermatogenesis. Fertil. Steril., 2000, 74, 251-256.
32. Jacobs, P.A. The chromosome complement of human gametes. Oxf. Rev. Reprod. Biol., 1992, 14, 47-72.
33. Rubes, J.; Vozdova, M.; Oracova, E.; Perreault, S.D. Individual variation in the frequency of sperm aneuploidy in humans. Cytogenet. Genome Res., 2005, 111, 229-236.
34. Rubes, J.; Vozdova, M.; Robbins, W.A.; Rezacova, O.; Perreault, S.D.; Wyrobek, A.J. Stable variants of sperm aneuploidy among healthy men show associations between germinal and somatic aneuploidy. Am. J. Hum. Genet., 2002, 70, 1507-1519.
35. Sarrate, Z.; Vidal, F.; Blanco, J. Role of sperm fluorescent in situ hybridization studies in infertile patients: indications, study approach, and clinical relevance. Fertil. Steril., 2010, 93, 1892-1902.
36. Soares, S.R.; Templado, C.; Blanco, J.; Egozcue, J.; Vidal, F. Numerical chromosome abnormalities in the spermatozoa of the fathers of children with trisomy 21 of paternal origin: generalized tendency to meiotic non- disjunction. Hum. Genet., 2001, 108, 134-139.
37. Tempest, H.G.; Ko, E.; Rademaker, A.; Chan, P.; Robaire, B.; Martin, R.H. Intra-individual and inter- individual variations in sperm aneuploidy frequencies in normal men. Fertil. Steril., 2009,91, 185-192.
38. Young, S.S.; Eskenazi, B.; Marchetti, F.M.; Block, G.; Wyrobek, A.J. The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men. Hum. Re- prod., 2008, 23, 1014-1022.
39. Aït Yahya-Graison, E.; Aubert, J.; Dauphinot, L.; Rivals, I.; Prieur, M.; Golfier, G.; Rossier, J.; Personnaz, L.; Creau, N.; Blehaut, H.; Robin, S.; Delabar, J.M.; Potier, M.C. Classification of human chromosome 21 gene- expression variations in Down syndrome: impact on disease phenotypes. Am. J. Hum. Genet., 2007, 81, 475-491.
40. Antonarakis, S.E.; Lyle, R.; Dermitzakis, E.T.; Reymond, A.; Deutsch, S. Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat. Rev. Genet., 2004, 5, 725-738.
41. Dierssen, M.; Herault, Y.; Estivill, X. Aneuploidy: from a physiological mechanism of variance to Down syndrome. Physiol. Rev., 2009, 89, 887-920.
42. Korenberg, J.R.; Chen, X.N.; Schipper, R.; Sun, Z.; Gonsky, R.; Gerwehr, S.; Carpenter, N.; Daumer, C.; Dignan, P.; Disteche, C.; et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl. Acad. Sci. USA, 1994, 91, 4997-5001.
43. Patterson, D. Molecular genetic analysis of Down syndrome. Hum. Genet., 2009, 126, 195-214.
44. Bornstein, E.; Lenchner, E.; Donnenfeld, A.; Kapp, S.; Keeler, S.M.; Divon, M.Y. Comparison of modes of ascertainment for mosaic vs complete trisomy 21. Am. J. Obstet. Gynecol., 2009, 200, 440 e441-445.
45. Papavassiliou, P.; York, T.P.; Gursoy, N.; Hill, G.; Nicely, L.V.; Sundaram, U.; McClain, A.; Aggen, S.H.; Eaves, L.; Riley, B.; Jackson-Cook, C. The phenotype of persons having mosaicism for trisomy 21/Down syndrome reflects the percentage of trisomic cells present in different tissues. Am. J. Med. Genet. A, 2009, 149A, 573-583.
46. Ringman, J.M.; Younkin, S.G.; Pratico, D.; Seltzer, W.; Cole, G.M.; Geschwind, D.H.; Rodriguez-Agudelo, Y.; Schaffer, B.; Fein, J.; Sokolow, S.; Rosario, E.R.; Gylys, K.H.; Varpetian, A.; Medina, L.D.; Cummings, J.L. Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology, 2008, 71, 85-92.
47. Sherman, S.L.; Allen, E.G.; Bean, L.H.; Freeman, S.B. Epidemiology of Down syndrome. Ment. Retard. Dev. Disabil. Res. Rev., 2007, 13, 221-227.
48. Shin, M.; Siffel, C.; Correa, A. Survival of children with mosaic Down syndrome. Am. J. Med. Genet. A, 2010, 152A, 800-801.
49. Sifakis, S.; Koukoura, O.; Mantas, N.; Velissariou, V.; Koumantakis, E. Hydrops fetalis, thickened placenta and other sonographic findings in a low-level trisomy 21 mosaicism: a case report. Fetal. Diagn. Ther., 2008, 24, 310-312.
50. Devlin, L.; Morrison, P.J. Mosaic Down's syndrome prevalence in a complete population study. Arch. Dis. Child., 2004, 89, 1177-1178.
51. Yurov, Y.B.; Vorsanova, S.G.; Iourov, I.Y. GIN'n'CIN hypothesis of brain aging: deciphering the role of somatic genetic instabilities and neural aneuploidy during ontogeny. Mol. Cytogenet., 2009, 2, 23.
52. Bergholdt, R.; Eising, S.; Nerup, J.; Pociot, F. Increased prevalence of Down's syndrome in individuals with type 1 diabetes in Denmark: A nationwide population-based study. Diabetologia, 2006, 49, 1179-1182.
53. Kusters, M.A.; Gemen, E.F.; Verstegen, R.H.; Wever, P.C.; de Vries, E. Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome Tlymphocytes. Pediatr. Res., 2010.
54. Fonatsch, C. The role of chromosome 21 in hematology and oncology. Genes Chromosomes Cancer, 2010, [Epub ahead of print].
55. Rabin, K.R.; Whitlock, J.A. Malignancy in children with trisomy 21. Oncologist, 2009, 14, 164-173.
56. Xavier, A.C.; Ge, Y.; Taub, J.W. Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology. J. Mol. Diagn., 2009, 11, 371-380.
57. Andersson, A.; Olofsson, T.; Lindgren, D.; Nilsson, B.; Ritz, C.; Eden, P.; Lassen, C.; Rade, J.; Fontes, M.; Morse, H.; Heldrup, J.; Behrendtz, M.; Mitelman, F.; Hoglund, M.; Johansson, B.; Fioretos, T. Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. Proc. Natl. Acad. Sci. USA, 2005, 102, 19069-19074.
58. Bercovich, D.; Ganmore, I.; Scott, L.M.; Wainreb, G.; Birger, Y.; Elimelech, A.; Shochat, C.; Cazzaniga, G.; Biondi, A.; Basso, G.; Cario, G.; Schrappe, M.; Stanulla, M.; Strehl, S.; Haas, O.A.; Mann, G.; Binder, V.; Borkhardt, A.; Kempski, H.; Trka, J.; Bielorei, B.; Avigad, S.; Stark, B.; Smith, O.; Dastugue, N.; Bourquin, J.P.; Tal, N.B.; Green, A.R.; Izraeli, S. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet, 2008, 372, 1484-1492.
59. Chokkalingam, A.P.; Buffler, P.A. Genetic susceptibility to childhood leukaemia. Radiat. Prot. Dosimetry, 2008, 132, 119-129.
60. Ganmore, I.; Smooha, G.; Izraeli, S. Constitutional aneuploidy and cancer predisposition. Hum. Mol. Genet., 2009, 18, R84-93.
61. Hertzberg, L.; Vendramini, E.; Ganmore, I.; Cazzaniga, G.; Schmitz, M.; Chalker, J.; Shiloh, R.; Iacobucci, I.; Shochat, C.; Zeligson, S.; Cario, G.; Stanulla, M.; Strehl, S.; Russell, L.J.; Harrison, C.J.; Bornhauser, B.; Yoda, A.; Rechavi, G.; Bercovich, D.; Borkhardt, A.; Kempski, H.; te Kronnie, G.; Bourquin, J.-P.; Domany, E.; Izraeli, S. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood, 2010, 115, 1006-1017.
62. Johansson, B.; Harrison, C.J., Acute myeloid leukemia. In: Cancer Cytogenetics, 3rd ed.; Heim, S.; Mitelman, F., Eds. Wiley-Blackwell: Hoboken, 2009; pp 45-139.
63. Karrman, K.; Forestier, E.; Andersen, M.K.; Autio, K.; Borgstrom, G.; Heim, S.; Heinonen, K.; Hovland, R.; Kerndrup, G.; Johansson, B. High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989-2005. Br. J. Haematol., 2006, 135, 352-354.
64. Kearney, L.; Gonzalez De Castro, D.; Yeung, J.; Procter, J.; Horsley, S.W.; Eguchi-Ishimae, M.; Bateman, C.M.; Anderson, K.; Chaplin, T.; Young, B.D.; Harrison, C.J.; Kempski, H.; So, C.W.; Ford, A.M.; Greaves, M. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. Blood, 2009, 113, 646-648.
65. Klusmann, J.H.; Li, Z.; Bohmer, K.; Maroz, A.; Koch, M.L.; Emmrich, S.; Godinho, F.J.; Orkin, S.H.; Reinhardt, D. miR125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev., 2010, 24, 478-490.
66. Korbel, J.O.; Tirosh-Wagner, T.; Urban, A.E.; Chen, X.N.; Kasowski, M.; Dai, L.; Grubert, F.; Erdman, C.; Gao, M.C.; Lange, K.; Sobel, E.M.; Barlow, G.M.; Aylsworth, A.S.; Carpenter, N.J.; Clark, R.D.; Cohen, M.Y.; Doran, E.; Falik-Zaccai, T.; Lewin, S.O.; Lott, I.T.; McGillivray, B.C.; Moeschler, J.B.; Pettenati, M.J.; Pueschel, S.M.; Rao, K.W.; Shaffer, L.G.; Shohat, M.; Van Riper, A.J.; Warburton, D.; Weissman, S.; Gerstein, M.B.; Snyder, M.; Korenberg, J.R. The genetic architecture of Down syndrome phenotypes revealed by high- resolution analysis of human segmental trisomies. Proc. Natl. Acad. Sci. USA, 2009, 106, 12031-12036.
67. Malinge, S.; Izraeli, S.; Crispino, J.D. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood, 2009, 113, 2619-2628.
68. Minelli, A.; Morerio, C.; Maserati, E.; Olivieri, C.; Panarello, C.; Bonvini, L.; Leszl, A.; Rosanda, C.; Lanino, E.; Danesino, C.; Pasquali, F. Meiotic origin of trisomy in neoplasms: evidence in a case of erythroleukaemia. Leukemia, 2001, 15, 971-975.
69. Mitelman, F.; Heim, S.; Mandahl, N. Trisomy 21 in neoplastic cells. Am. J. Med. Genet. Suppl., 1990, 7, 262-266.
70. Tsuzuki, S.; Karnan, S.; Horibe, K.; Matsumoto, K.; Kato, K.; Inukai, T.; Goi, K.; Sugita, K.; Nakazawa, S.; Kasugai, Y.; Ueda, R.; Seto, M. Genetic abnormalities involved in t(12;21) TELAML1 acute lymphoblastic leukemia: analysis by means of arraybased comparative genomic hybridization. Cancer Sci., 2007, 98, 698-706.
71. Webb, D.; Roberts, I.; Vyas, P. Haematology of Down syndrome. Arch. Dis. Child. Fetal Neonatal Ed., 2007, 92, F503-507.
72. Zwaan, C.M.; Reinhardt, D.; Hitzler, J.; Vyas, P. Acute leukemias in children with Down syndrome. Hematol. Oncol. Clin. North Am., 2010, 24, 19-34.
73. Forestier, E.; Izraeli, S.; Beverloo, B.; Haas, O.; Pession, A.; Michalova, K.; Stark, B.; Harrison, C.J.; Teigler-Schlegel, A.; Johansson, B. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study. Blood, 2008, 111, 1575-1583.
74. Burjanivova, T.; Madzo, J.; Muzikova, K.; Meyer, C.; Schneider, B.; Votava, F.; Marschalek, R.; Stary, J.; Trka, J.; Zuna, J. Prenatal origin of childhood AML occurs less frequently than in childhood ALL. BMC Cancer, 2006, 6, 100.
75. Ford, A.M.; Palmi, C.; Bueno, C.; Hong, D.; Cardus, P.; Knight, D.; Cazzaniga, G.; Enver, T.; Greaves, M. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. J. Clin. Invest., 2009, 119, 826-836.
76. Ford, A.M.; Ridge, S.A.; Cabrera, M.E.; Mahmoud, H.; Steel, C.M.; Chan, L.C.; Greaves, M. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature, 1993, 363, 358-360.
77. Gale, K.B.; Ford, A.M.; Repp, R.; Borkhardt, A.; Keller, C.; Eden, O.B.; Greaves, M.F. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc. Natl. Acad. Sci. USA, 1997, 94, 13950-13954.
78. Gruhn, B.; Taub, J.W.; Ge, Y.; Beck, J.F.; Zell, R.; Hafer, R.; Hermann, F.H.; Debatin, K.M.; Steinbach, D. Prenatal origin of childhood acute lymphoblastic leukemia, association with birth weight and hyperdiploidy. Leukemia, 2008, 22, 1692-1697.
79. Hellebostad, M.; Carpenter, E.; Hasle, H.; Mitchell, C.; Vyas, P. GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis. J. Pediatr. Hematol. Oncol., 2005, 27, 408-409.
80. Hong, D.; Gupta, R.; Ancliff, P.; Atzberger, A.; Brown, J.; Soneji, S.; Green, J.; Colman, S.; Piacibello, W.; Buckle, V.; Tsuzuki, S.; Greaves, M.; Enver, T. Initiating and cancer- propagating cells in TEL-AML1- associated childhood leukemia. Science, 2008, 319, 336-339.
81. Maia, A.T.; van der Velden, V.H.; Harrison, C.J.; Szczepanski, T.; Williams, M.D.; Griffiths, M.J.; van Dongen, J.J.; Greaves, M.F. Prenatal origin of hyperdiploid acute lymphoblastic leukemia in identical twins. Leukemia, 2003, 17, 2202-2206.
82. Rossig, C.; Juergens, H. Aetiology of childhood acute leukaemias: current status of knowledge. Radiat. Prot. Dosimetry, 2008, 132, 114-118.
83. Wiemels, J.; Kang, M.; Greaves, M. Backtracking of leukemic clones to birth. Methods Mol. Biol., 2009, 538, 7-27.
84. De Miguel, M.P.; Arnalich Montiel, F.; Lopez Iglesias, P.; Blazquez Martinez, A.; Nistal, M. Epiblastderived stem cells in embryonic and adult tissues. mnt. J. Dev. Biol., 2009, 53, 1529-1540.
85. Sussan, T.E.; Yang, A.; Li, F.; Ostrowski, M.C.; Reeves, R.H. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature, 2008, 451, 73-75.
86. Threadgill, D.W. Down's syndrome: paradox of a tumour repressor. Nature, 2008, 451, 21-22.
87. Yu, J.; Zhang, Y.; Qi, Z.; Kurtycz, D.; Vacano, G.; Patterson, D. Methylation-mediated downregulation of the B-cell translocation gene 3 (BTG3) in breast cancer cells. Gene Expr., 2008, 14, 173-182.
88. Baek, K.H.; Zaslavsky, A.; Lynch, R.C.; Britt, C.; Okada, Y.; Siarey, R.J.; Lensch, M.W.; Park, I.H.; Yoon, S.S.; Minami, T.; Korenberg, J.R.; Folkman, J.; Daley, G.Q.; Aird, W.C.; Galdzicki, Z.; Ryeom, S. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor D SCR1. Nature, 2009, 459, 1126-1130.
89. Gopalan, A.; Leversha, M.A.; Satagopan, J.M.; Zhou, Q.; Al-Ahmadie, H.A.; Fine, S.W.; Eastham, J.A.; Scardino, P.T.; Scher, H.I.; Tickoo, S.K.; Reuter, V.E.; Gerald, W.L. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Res., 2009, 69, 1400-1406.
90. Tomlins, S.A.; Rhodes, D.R.; Perner, S.; Dhanasekaran, S.M.; Mehra, R.; Sun, X.W.; Varambally, S.; Cao, X.; Tchinda, J.; Kuefer, R.; Lee, C.; Montie, J.E.; Shah, R.B.; Pienta, K.J.; Rubin, M.A.; Chinnaiyan, A.M. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science, 2005, 310, 644-648.
91. Ryeom, S.; Baek, K.H.; Zaslavsky, A. Down's syndrome: protection against cancer and the therapeutic potential of DSCR1. Future Oncol., 2009, 5, 1185-1188.
92. Patja, K.; Pukkala, E.; Sund, R.; Iivanainen, M.; Kaski, M. Cancer incidence of persons with Down syndrome in Finland: a population-based study. mnt. J. Cancer, 2006, 118, 1769-1772.
93. Wohlfahrt-Veje, C.; Main, K.M.; Skakkebaek, N.E. Testicular dysgenesis syndrome: foetal origin of adult reproductive problems. Clin. Endocrinol. (Oxf), 2009, 71, 459-465.
94. Yang, Q.; Rasmussen, S.A.; Friedman, J.M. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet, 2002, 359, 1019-1025.
95. Klein, G. Toward a genetics of cancer resistance. Proc. Natl. Acad. Sci. USA, 2009, 106, 859-863.
96. Turleau, C.; Vekemans, M. [Trisomy 21: fifty years between medicine and science]. Med. Sci. (Paris), 2010, 26, 267-272.
97. Cairney, C.J.; Sanguinetti, G.; Ranghini, E.; Chantry, A.D.; Nostro, M.C.; Bhattacharyya, A.; Svendsen, C.N.; Keith, W.N.; Bellantuono, I. A systems biology approach to Down syndrome: identification of Notch/Wnt dysregulation in a model of stem cells aging. Biochim. Biophys. Acta, 2009, 1792, 353-363.
98. Kingsbury, M.A.; Yung, Y.C.; Peterson, S.E.; Westra, J.W.; Chun, J. Aneuploidy in the normal and diseased brain. Cell. Mol. Life. Sci., 2006, 63, 2626-2641.
99. Potter, H. Review and hypothesis: Alzheimer disease and Down syndrome-chromosome 21 nondisjunction may underlie both disorders. Am. J. Hum. Genet., 1991, 48, 1192-1200.
100. Coppedè, F.; Migliore, L. Evidence Linking Genetics, Environment, and Epigenetics to Impaired DNA Repair in Alzheimer's Disease. J. Alzheimers Dis., 2010.
101. Cossec, J.C.; Marquer, C.; Panchal, M.; Lazar, A.N.; Duyckaerts, C.; Potier, M.C. Cholesterol changes in Alzheimer's disease: Methods of analysis and impact on the formation of enlarged endosomes. Biochim. Biophys. Acta, 2010.
102. Granic, A.; Padmanabhan, J.; Norden, M.; Potter, H. Alzheimer Abeta peptide induces chromosome missegregation and aneuploidy, including trisomy 21: requirement for tau and APP. Mol. Biol. Cell, 2010, 21, 511-520.
103. Jang, H.; Arce, F.T.; Ramachandran, S.; Capone, R.; Azimova, R.; Kagan, B.L.; Nussinov, R.; Lal, R. Truncated {beta} - amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome. Proc. Natl. Acad. Sci. USA, 2010.
104. Nagy, Z. The dysregulation of the cell cycle and the diagnosis of Alzheimer's disease. Biochim. Biophys. Acta, 2007, 1772, 402-408.
105. Querfurth, H.W.; LaFerla, F.M. Alzheimer's disease. N. Engl. J. Med., 2010, 362, 329-344.
106. Migliore, L.; Botto, N.; Scarpato, R.; Petrozzi, L.; Cipriani, G.; Bonuccelli, U. Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients. Cytogenet. Cell. Genet., 1999, 87, 41-46.
107. Migliore, L.; Testa, A.; Scarpato, R.; Pavese, N.; Petrozzi, L.; Bonuccelli, U. Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum. Genet., 1997, 101, 299-305.
108. Petrozzi, L.; Lucetti, C.; Scarpato, R.; Gambaccini, G.; Trippi, F.; Bernardini, S.; Del Dotto, P.; Migliore, L.; Bonuccelli, U. Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients. Neurol. Sci., 2002, 23 Suppl 2, S97-98.
109. Potter, H. Down's syndrome and Alzheimer's disease: two sides of the same coin. Future Neurol., 2008, 3, 29-37.
110. Trippi, F.; Botto, N.; Scarpato, R.; Petrozzi, L.; Bonuccelli, U.; Latorraca, S.; Sorbi, S.; Migliore, L. Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer's disease patients. Muta genesis, 2001, 16, 323-327.
111. Heston, L.L.; Mastri, A.R. The genetics of Alzheimer's disease: associations with hematologic malignancy and Down's syndrome. Arch. Gen. Psychiatry, 1977, 34, 976-981.
112. Heston, L.L.; Mastri, A.R.; Anderson, V.E.; White, J. Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions. Arch. Gen. Psychiatry, 1981, 38, 1085-1090.
113. Heyman, A.; Wilkinson, W.E.; Hurwitz, B.J.; Schmechel, D.; Sigmon, A.H.; Weinberg, T.; Helms, M.J.; Swift, M. Alzheimer's disease: genetic aspects and associated clinical disorders. Ann. Neurol., 1983, 14, 507-515.
114. Mosconi, L.; Rinne, J.O.; Tsui, W.H.; Berti, V.; Li, Y.; Wang, H.; Murray, J.; Scheinin, N.; Nagren, K.; Williams, S.; Glodzik, L.; De Santi, S.; Vallabhajosula, S.; de Leon, M.J. Increased fibrillar amyloid-{ beta} burden in normal individuals with a family history of late-onset Alzheimer's. Proc. Natl. Acad. Sci. USA, 2010, 107, 5949-5954.
115. Iourov, I.Y.; Vorsanova, S.G.; Liehr, T.; Yurov, Y.B. Aneuploidy in the normal, Alzheimer's disease and ataxiatelangiectasia brain: differential expression and pathological meaning. Neurobiol. Dis.,2009, 34, 212-220.
116. Prasher, V.P.; Farrer, M.J.; Kessling, A.M.; Fisher, E.M.; West, R.J.; Barber, P.C.; Butler, A.C. Molecular mapping of Alzheimertype dementia in Down's syndrome. Ann. Neurol., 1998, 43, 380-383.
117. Migliore, L.; Boni, G.; Bernardini, R.; Trippi, F.; Colognato, R.; Fontana, I.; Coppede, F.; Sbrana, I. Susceptibility to chromosome malsegregation in lymphocytes of women who had a Down syndrome child in young age. Neurobiol. Aging, 2006, 27, 710-716.
118. Schupf, N.; Kapell, D.; Nightingale, B.; Lee, J.H.; Mohlenhoff, J.; Bewley, S.; Ottman, R.; Mayeux, R. Specificity of the fivefold increase in AD in mothers of adults with Down syndrome. Neurology, 2001, 57, 979-984.
119. Antonarakis, S.E.; Avramopoulos, D.; Blouin, J.L.; Talbot, C.C., Jr.; Schinzel, A.A. Mitotic errors in somatic cells cause trisomy 21 in about 4.5% of cases and are not associated with advanced maternal age. Nat. Genet., 1993, 3, 146-150.
120. Pangalos, C.; Avramopoulos, D.; Blouin, J.L.; Raoul, O.; de- Blois, M.C.; Prieur, M.; Schinzel, A.A.; Gika, M.; Abazis, D.; Antonarakis, S.E. Understanding the mechanism(s) of mosaic trisomy 21by using DNA polymorphism analysis. Am. J. Hum. Genet., 1994, 54, 473-481.
121. Katz-Jaffe, M.G.; Trounson, A.O.; Cram, D.S. Chromosome 21 mosaic human preimplantation embryos predominantly arise from diploid conceptions. Fertil. Steril., 2005, 84, 634-643.
122. Conlin, L.K.; Thiel, B.D.; Bonnemann, C.G.; Medne, L.; Ernst, L.M.; Zackai, E.H.; Deardorff, M.A.; Krantz, I.D.; Hakonarson, H.; Spinner, N.B. Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum. Mol. Genet., 2010, 19, 1263-1275.
123. Iourov, I.Y.; Liehr, T.; Vorsanova, S.G.; Kolotii, A.D.; Yurov, Y.B. Visualization of interphase chromosomes in postmitotic cells of the human brain by multicolour banding (MCB). Chromosome Res., 2006, 14, 223-229.
124. Vanneste, E.; Voet, T.; Le Caignec, C.; Ampe, M.; Konings, P.; Melotte, C.; Debrock, S.; Amyere, M.; Vikkula, M.; Schuit, F.; Fryns, J.P.; Verbeke, G.; D'Hooghe, T.; Moreau, Y.; Vermeesch, J.R. Chromosome instability is common in human cleavage-stage embryos. Nat. Med., 2009, 15, 577-583.
125. Engel, E. A fascination with chromosome rescue in uniparental disomy: Mendelian recessive outlaws and imprinting copyrights infringements. Eur. J. Hum. Genet., 2006, 14, 1158-1169.
126. Engel, E.; Antonarakis, S.E., Genomic Imprinting and Uniparental Disomy in Medicine. Clinical and Molecular Aspects. Wiley-Liss Inc: New York, 2002.
127. Liehr, T. Cytogenetic contribution to uniparental disomy (UPD). Mol. Cytogenet., 2010, 3, 8.
128. Roe, C.M.; Fitzpatrick, A.L.; Xiong, C.; Sieh, W.; Kuller, L.; Miller, J.P.; Williams, M.M.; Kopan, R.; Behrens, M.I.; Morris, J.C. Cancer linked to Alzheimer disease but not vascular dementia. Neurology, 2010, 74, 106-112.
129. Farlie, I. Childhood cancer near German nuclear power stations. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev., 2010, 28, 1-21.
130. McNally, R.J.; Rankin, J.; Shirley, M.D.; Rushton, S.P.; Pless-Mulloli, T. Space-time analysis of Down syndrome: results consistent with transient pre-disposing contagious agent. Int. J. Epidemiol., 2008, 37, 1169-1179.
131. Morris, J.K. Commentary: Clustering in Down syndrome. Int. J. Epidemiol., 2008, 37, 1179-1180.
132. Vorsanova, S.G.; Iourov, I.Y.; Beresheva, A.K.; Demidova, I.A.; Monakhov, V.V.; Kravets, V.S.; Bartseva, O.B.; Goyko, E.A.; Soloviev, I.V.; Yurov, Y.B. Non-disjunction of chromosome 21, alphoid DNA variation, and sociogenetic features of Down syndrome. Tsitol. Genet., 2005, 39, 30-36.
133. Vorsanova, S.G.; Kolotii, A.D.; Iourov, I.Y.; Monakhov, V.V.; Kirillova, E.A.; Soloviev, I.V.; Yurov, Y.B. Evidence for high frequency of chromosomal mosaicism in spontaneous abortions revealed by interphase FISH analysis. J. Histochem. Cytochem., 2005, 53, 375-380.
134. Blank, C.E.; Gemmell, E.; Casey, M.D.; Lord, M. Mosaicism in a mother with a mongol child. Br. Med. J., 1962, 2, 378-380.
135. Clarke, C.M.; Edwards, J.H.; Smallpeice, V. 21-trisomy/normal mosaicism in an intelligent child with some mongoloid characters. Lancet, 1961, 277, 1028-1030.
136. Fitzgerald, P.H.; Lycette, R.R. Mosaicism involving the auto- some associated with mongolism. Lancet, 1961, 278, 212.
137. Hayashi, T.; Hsu, T.C.; Chao, D. A case of mosaicism in mongolism Lancet, 1962, 279, 218-219.
138. Nichols, W.W.; Coriell, L.L.; Fabrizio, D.P.; Bishop, H.C.; Boggs, T.R., Jr. Mongolism with mosaic chromosome pattern. J. Pediatr., 1962, 60, 69-76.
139. Richards, B.W.; Stewart, A. Mosaicism in a mongol. Lancet, 1962, 279, 275-276.
140. Edelstein, J.; Amylon, M.; Walsh, J.A. Dermatoglyphics and acute lymphocytic leukemia in children. J. Pediatr. Oncol. Nurs., 1991, 8, 30-38.
141. Oorthuys, A.M.; de Vaan, G.A.; Behrendt, H.; Geerts, S.J. Palmar flexion creases in childhood neoplasia. Cancer, 1979, 43, 749-759.
142. Faddy, M.J. Follicle dynamics during ovarian ageing. Mol. Cell. Endocrinol., 2000, 163, 43-48.
143. Morris, J.K.; Mutton, D.E.; Alberman, E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J. Med. Screen., 2002, 9, 2-6.